EUVIMEDDescoperă EUVIMED
Open access

Increased expression of phosphodiesterase 4 in activated hepatic stellate cells promotes cytoskeleton remodeling and cell migration

Mohamed Elnagdy, Yali Wang, Walter Rodriguez, JingWen Zhang, Philip Bauer, Daniel W Wilkey, Michael Merchant, Jianmin Pan, Zainab Farooqui, Robert Cannon, Shesh Rai, Claudio Maldonado and 3 more

The Journal of Pathology · 2023-11 · 261 (3) · 361-371

DOI: 10.1002/path.6194 ↗

At a glance

Journal article in The Journal of Pathology, published online on 2023-09-21. Written by Mohamed Elnagdy and 14 co-authors. Institution: University of Louisville Alcohol Research Center, Louisville, KY, USA. Major MEDLINE topics: Actins, Cyclic Nucleotide Phosphodiesterases, Type 4. Cited 18 times so far (Crossref); 69 references. The full text is freely available in PubMed Central. Funded by: NIH HHS, NIGMS NIH HHS, NIAAA NIH HHS.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Activation and transdifferentiation of hepatic stellate cells (HSC) into migratory myofibroblasts is a key process in liver fibrogenesis. Cell migration requires an active remodeling of the cytoskeleton, which is a tightly regulated process coordinated by Rho‐specific guanine nucleotide exchange factors (GEFs) and the Rho family of small GTPases. Rho‐associated kinase (ROCK) promotes assembly of focal adhesions and actin stress fibers by regulating cytoskeleton organization. GEF exchange protein directly activated by cAMP 1 (EPAC1) has been implicated in modulating TGFβ1 and Rho signaling; however, its role in HSC migration has never been examined. The aim of this study was to evaluate the role of cAMP‐degrading phosphodiesterase 4 (PDE4) enzymes in regulating EPAC1 signaling, HSC migration, and fibrogenesis. We show that PDE4 protein expression is increased in activated HSCs expressing alpha smooth muscle actin and active myosin light chain (MLC) in fibrotic tissues of human nonalcoholic steatohepatitis cirrhosis livers and mouse livers exposed to carbon tetrachloride. In human livers, TGFβ1 levels were highly correlated with PDE4 expression. TGFβ1 treatment of LX2 HSCs decreased levels of cAMP and EPAC1 and increased PDE4D expression. PDE4 specific inhibitor, rolipram, and an EPAC‐specific agonist decreased TGFβ1‐mediated cell migration in vitro . In vivo , targeted delivery of rolipram to the liver prevented fibrogenesis and collagen deposition and decreased the expression of several fibrosis‐related genes, and HSC activation. Proteomic analysis of mouse liver tissues identified the regulation of actin cytoskeleton by the kinase effectors of Rho GTPases as a major pathway impacted by rolipram. Western blot analyses confirmed that PDE4 inhibition decreased active MLC and endothelin 1 levels, key proteins involved in cytoskeleton remodeling and contractility. The current study, for the first time, demonstrates that PDE4 enzymes are expressed in hepatic myofibroblasts and promote cytoskeleton remodeling and HSC migration. © 2023 The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

ActinsCyclic Nucleotide Phosphodiesterases, Type 4AnimalsHumansMiceCell MovementCytoskeletonFibrosisHepatic Stellate CellsLiver CirrhosisProteomicsRolipram

Author keywords

cell migrationcyclic AMP signalingcytoskeleton remodelinghepatic stellate cellsliver fibrosisphosphodiesterase 4proteomics

Substances

ActinsCyclic Nucleotide Phosphodiesterases, Type 4RolipramPDE4A protein, humanPde4a protein, mouse

Authors and institutions

  • University of Louisville Alcohol Research Center, Louisville, KY, USA.
  • Hepatobiology and Toxicology Center, Louisville, KY, USA.
  • Department of Pharmacology and Toxicology, School of Medicine, Louisville, KY, USA.
  • Department of Physiology, School of Medicine, University of Louisville, Louisville, KY, USA.
  • Department of Medicine, School of Medicine, Louisville, KY, USA.
  • EndoProtech, Inc, Louisville, KY, USA.

ORCID profiles: Leila Gobejishvili

Funding

  • NIH HHS
  • NIGMS NIH HHS
  • NIAAA NIH HHS
  • National Institutes of Health

Cite

APA

Elnagdy, M., Wang, Y., Rodriguez, W., Zhang, J., Bauer, P., Wilkey, D. W., Merchant, M., Pan, J., Farooqui, Z., Cannon, R., Rai, S., Maldonado, C., Barve, S., McClain, C. J., & Gobejishvili, L. (2023). Increased expression of phosphodiesterase 4 in activated hepatic stellate cells promotes cytoskeleton remodeling and cell migration. The Journal of Pathology, 261(3), 361-371. https://doi.org/10.1002/path.6194

Vancouver

Elnagdy M, Wang Y, Rodriguez W, Zhang J, Bauer P, Wilkey DW, et al. Increased expression of phosphodiesterase 4 in activated hepatic stellate cells promotes cytoskeleton remodeling and cell migration. The Journal of Pathology. 2023;261(3):361-371. doi:10.1002/path.6194

BibTeX
@article{Elnagdy2023,
  author = {Elnagdy, Mohamed and Wang, Yali and Rodriguez, Walter and Zhang, JingWen and Bauer, Philip and Wilkey, Daniel W and Merchant, Michael and Pan, Jianmin and Farooqui, Zainab and Cannon, Robert and Rai, Shesh and Maldonado, Claudio and Barve, Shirish and McClain, Craig J and Gobejishvili, Leila},
  title = {Increased expression of phosphodiesterase 4 in activated hepatic stellate cells promotes cytoskeleton remodeling and cell migration},
  journal = {The Journal of Pathology},
  year = {2023},
  volume = {261},
  number = {3},
  pages = {361--371},
  doi = {10.1002/path.6194}
}
Start for free →